title: [Pneumocystis pneumonia in a renal transplant recipient].
abstract: Pneumocystis pneumonia (PCP) is an opportunistic infection caused by Pneumocystis jirovecii (P. jirovecii) in humans. We reported a 23 year-old male patient who developed pneumonia after renal transplantation. P. jirovecii cysts and trophozoites were detected in bronchoalveolar lavage (BAL) samples of the patient by Giemsa, methenamine-silver and Toluidine-O staining. The patient, who was diagnosed as PCP, was discharged as he recovered by 21 days trimethoprim-sulfamethoxazole (TMP-SMX) therapy. This case, who developed PCP even though he had received prophylaxis after transplantation, was reported to emphasize the importance of the agent in immunocompromised patients.
authors.affiliation: Dokuz Eylül Üniversitesi Tıp Fakültesi, Parazitoloji Anabilim Dalı, İzmir, Türkiye. soykan.ozkoc@deu.edu.tr
authors.forename: Soykan
authors.initials: S
authors.lastname: Özkoç
authors.forename: Tonay
authors.initials: T
authors.lastname: İnceboz
authors.forename: Aykut
authors.initials: A
authors.lastname: Sıfıl
authors.forename: Sema
authors.initials: S
authors.lastname: Tuncay
authors.forename: Çiler
authors.initials: Ç
authors.lastname: Akisü
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D001992:Bronchoalveolar Lavage Fluid / Q000469:parasitology; D006801:Humans; D016867:Immunocompromised Host; D016030:Kidney Transplantation; D008297:Male; D009894:Opportunistic Infections / Q000188:drug therapy / Q000209:etiology* / Q000469:parasitology; D045363:Pneumocystis carinii / Q000302:isolation & purification*; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy / Q000209:etiology* / Q000469:parasitology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination